The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis
A Blauvelt, A Chiricozzi - Clinical reviews in allergy & immunology, 2018 - Springer
Psoriasis is a chronic, immune-mediated, inflammatory disease that is pathogenically driven
by proinflammatory cytokines. This article reviews the immunologic role of interleukin (IL)-17 …
by proinflammatory cytokines. This article reviews the immunologic role of interleukin (IL)-17 …
[HTML][HTML] Psoriatic arthritis
V Ocampo, D Gladman - F1000Research, 2019 - ncbi.nlm.nih.gov
Psoriasis is a multisystemic, inflammatory skin condition that can affect many areas of the
body, but most commonly the extensor surfaces of the elbows and knees, and sometimes …
body, but most commonly the extensor surfaces of the elbows and knees, and sometimes …
[HTML][HTML] Tofacitinib or adalimumab versus placebo for psoriatic arthritis
P Mease, S Hall, O FitzGerald… - … England Journal of …, 2017 - Mass Medical Soc
Background Tofacitinib is an oral Janus kinase inhibitor that is under investigation for the
treatment of psoriatic arthritis. We evaluated tofacitinib in patients with active psoriatic …
treatment of psoriatic arthritis. We evaluated tofacitinib in patients with active psoriatic …
[HTML][HTML] Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors
D Gladman, W Rigby, VF Azevedo… - … England Journal of …, 2017 - Mass Medical Soc
Background Tofacitinib is an oral Janus kinase inhibitor that is under investigation for the
treatment of psoriatic arthritis. We evaluated tofacitinib in patients with active psoriatic …
treatment of psoriatic arthritis. We evaluated tofacitinib in patients with active psoriatic …
[HTML][HTML] Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week …
PJ Mease, D van der Heijde, CT Ritchlin… - Annals of the …, 2017 - ard.bmj.com
Objective To assess the safety and efficacy of ixekizumab, a monoclonal antibody that
inhibits interleukin-17A, in a double-blind phase III trial enrolling patients with active …
inhibits interleukin-17A, in a double-blind phase III trial enrolling patients with active …
[HTML][HTML] Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
ML Halling, J Kjeldsen, T Knudsen… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To investigate whether immune mediated diseases (IMD) are more frequent in patients
with inflammatory bowel disease (IBD). METHODS In this population based registry study, a …
with inflammatory bowel disease (IBD). METHODS In this population based registry study, a …
Clinical characteristics, disease activity, and patient‐reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the Corrona Psoriatic …
PJ Mease, C Karki, JB Palmer, CJ Etzel… - Arthritis care & …, 2017 - Wiley Online Library
Objective To characterize psoriatic arthritis (PsA) patients with dactylitis or enthesitis and
evaluate the associations of these manifestations with disease activity and patient‐reported …
evaluate the associations of these manifestations with disease activity and patient‐reported …
Prolactin and autoimmunity: The hormone as an inflammatory cytokine
VV Borba, G Zandman-Goddard, Y Shoenfeld - Best Practice & Research …, 2019 - Elsevier
Nowadays, more than 80 autoimmune disorders are recognized, in which an aberrant
immune response against different organs and tissues plays a crucial role. Hormonal …
immune response against different organs and tissues plays a crucial role. Hormonal …
Interleukin-17A interweaves the skeletal and immune systems
M Tang, L Lu, X Yu - Frontiers in Immunology, 2021 - frontiersin.org
The complex crosstalk between the immune and the skeletal systems plays an
indispensable role in the maintenance of skeletal homeostasis. Various cytokines are …
indispensable role in the maintenance of skeletal homeostasis. Various cytokines are …
Psoriatic arthritis: what is happening at the joint?
J Belasco, N Wei - Rheumatology and Therapy, 2019 - Springer
Psoriatic arthritis (PsA) is a heterogeneous and inflammatory disease with diverse clinical
manifestations, including psoriasis, nail psoriasis, peripheral joint disease, axial joint …
manifestations, including psoriasis, nail psoriasis, peripheral joint disease, axial joint …